ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET


BAUDETTE, Minn.--(BUSINESS WIRE)--Jul. 25, 2022-- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2022 financial results on Monday, August 8, 2022, prior to market open.

Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:



Monday, August 8, 2022



8:00 a.m. ET

Toll free (U.S.)



Webcast (live and replay), under the “Investors” section

A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for two weeks by dialing 800-753-6121 and entering access code 7163806.

About ANI
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is a diversified biopharmaceutical company serving patients by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin® Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.

Faith Pomeroy-Ward, Director, Commercial Market Development, ANI Pharmaceuticals
SOURCE: ANI Pharmaceuticals, Inc.

Source: ANI Pharmaceuticals, Inc.